
OhMD is a HIPAA-compliant patient communication platform designed to streamline communication between healthcare providers and patients. The platform offers features such as two-way SMS and secure texting, call-to-text, web chat, and electronic forms. It aims to automate workflows, improve care coordination, and scale operations for healthcare practices. OhMD integrates with over 85 EHR solutions and offers an AI assistant for patient calls. The company's business model appears to be a combination of free basic services and paid tiers for enhanced features like text-enablement of landlines and advanced automation. They are trusted by over 5,000 organizations and aim to improve patient experience and practice efficiency.

OhMD is a HIPAA-compliant patient communication platform designed to streamline communication between healthcare providers and patients. The platform offers features such as two-way SMS and secure texting, call-to-text, web chat, and electronic forms. It aims to automate workflows, improve care coordination, and scale operations for healthcare practices. OhMD integrates with over 85 EHR solutions and offers an AI assistant for patient calls. The company's business model appears to be a combination of free basic services and paid tiers for enhanced features like text-enablement of landlines and advanced automation. They are trusted by over 5,000 organizations and aim to improve patient experience and practice efficiency.
Product: HIPAA-compliant patient communication platform with two-way SMS, secure messaging, voice AI, web chat, telehealth video, and forms
Customers: Trusted by over 5,000 healthcare organizations
EHR Integrations: Integrates with 85+ EHRs and practice management systems
Funding: Has raised outside capital including a 2017 $1.2M seed and a financing led by FCA Venture Partners in Feb 2022
Healthcare provider–patient communication and care coordination.
Healthtech / Healthcare Communications
1200000.00
Seed round announced March 3, 2017
Latest announced financing led by FCA Venture Partners with co-investment from the Dudley Fund
“Has attracted institutional investors across multiple rounds including Eideard Venture Capital and FCA Venture Partners”